Tianyu Wang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Tianyu Wang has a total of 29 co-authors. Here are the top co-authors by number of shared publications:
- Hirofumi Tanaka
The University of Texas at Austin
7 shared publications - Natalie McLaurin
The University of Texas at Austin
3 shared publications - Dixie Stanforth
Department of Kinesiology and Health Education The University of Texas at Austin Austin, TX United States
2 shared publications - Henry Matthew Lehrer
Health and Human Development Department, University of Pittsburgh , Pittsburgh, PA
2 shared publications - James Stuart Wolf
Department of Surgery and Perioperative Care, Dell Medical School of the University of Texas at Austin , Austin, Texas
2 shared publications Lin-Sheng Chen
Affiliation Department of Kinesiology and Health Education, The University of Texas at Austin, Austin, Texas, United States of America
2 shared publications
Latest Publications
- Open Access
- 13 August 2026
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 21 (8) , e0345338
The impact of short-term reduction in hepatic triglycerides on vascular health in adults with or at risk of metabolic dysfunction-associated steatotic liver disease
Background: Metabolic dysfunction-associated steatotic liver disease (MASLD) increases cardiovascular risk, but the vascular benefits of reducing hepatic triglycerides remain unclear. Aim: To determine whether short-term diet-induced reductions in hepatic triglycerides improve arterial stiffness and endothelial function. Methods: In a two-week, two-arm pre-post dietary intervention trial, adults with MASLD or elevated risk were assigned to either a low-carbohydrate (<30 g carbohydrate/day, n = 24) or low-calorie diet (~1,200−1,500 kcal/day, n = 23). Hepatic triglyceride content was assessed using proton density fat fraction magnetic resonance imaging. Vascular assessments included arterial stiffness as assessed by pulse wave velocity (PWV), and endothelial function via brachial artery flow-mediated dilation (FMD). The Framingham Risk Score (FRS) was evaluated pre- and post-intervention. Results: At baseline, 31 of 47 participants had MASLD. In the total sample, hepatic triglyceride content decreased by 15% relative to baseline (p < 0.001), with no significant differences between the two diet groups. Brachial-ankle PWV decreased by 41 cm/s (p = 0.001). FRS decreased (p < 0.001) and FMD (p = 0.030) increased by ~1.0% in absolute terms. Reductions in hepatic triglyceride content were positively correlated with changes in heart rate at rest (r = 0.49, p = 0.001), even after the adjustment of age and body weight change (r = 0.35, p = 0.021). Conclusions: Vascular function improvements and cardiovascular risk reductions occurred along with hepatic triglyceride reduction following a two-week dietary intervention. Changes in hepatic triglyceride content were positively correlated with the corresponding changes in heart rate but not with measures of vascular function. (ClinicalTrials.gov, NCT05216796).
- 13 August 2026
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 21 (8) , e0345338
Open AccessThe impact of short-term reduction in hepatic triglycerides on vascular health in adults with or at risk of metabolic dysfunction-associated steatotic liver disease
Background: Metabolic dysfunction-associated steatotic liver disease (MASLD) increases cardiovascular risk, but the vascular benefits of reducing hepatic triglycerides remain unclear. Aim: To determine whether short-term diet-induced reductions in hepatic triglycerides improve arterial stiffness and endothelial function. Methods: In a two-week, two-arm pre-post dietary intervention trial, adults with MASLD or elevated risk were assigned to either a low-carbohydrate (<30 g carbohydrate/day, n = 24) or low-calorie diet (~1,200−1,500 kcal/day, n = 23). Hepatic triglyceride content was assessed using proton density fat fraction magnetic resonance imaging. Vascular assessments included arterial stiffness as assessed by pulse wave velocity (PWV), and endothelial function via brachial artery flow-mediated dilation (FMD). The Framingham Risk Score (FRS) was evaluated pre- and post-intervention. Results: At baseline, 31 of 47 participants had MASLD. In the total sample, hepatic triglyceride content decreased by 15% relative to baseline (p < 0.001), with no significant differences between the two diet groups. Brachial-ankle PWV decreased by 41 cm/s (p = 0.001). FRS decreased (p < 0.001) and FMD (p = 0.030) increased by ~1.0% in absolute terms. Reductions in hepatic triglyceride content were positively correlated with changes in heart rate at rest (r = 0.49, p = 0.001), even after the adjustment of age and body weight change (r = 0.35, p = 0.021). Conclusions: Vascular function improvements and cardiovascular risk reductions occurred along with hepatic triglyceride reduction following a two-week dietary intervention. Changes in hepatic triglyceride content were positively correlated with the corresponding changes in heart rate but not with measures of vascular function. (ClinicalTrials.gov, NCT05216796).
- Open Access
- 25 June 2026
- Published by Springer Nature in Journal of Racial and Ethnic Health Disparities
Psychological Resilience Profiles and Their Association with Socioemotional Health and HbA1c Among African American Adults with Type 2 Diabetes: A Latent Profile Analysis
Objective: We used a cross-sectional design with baseline data from a Type 2 diabetes (T2D) clinical trial to (1) identify resilience profiles among African American adults with T2D and (2) examine the profiles’ associations with perceived social support, diabetes distress, depressive symptoms, and Hemoglobin A1c (HbA1c) levels. Methods: Participants ( n = 284, 72% women, 62 ± 11 years) recruited through churches in Central Texas completed a questionnaire assessing perceived psychological resilience, social support, diabetes distress, and depressive symptoms. HbA1c was obtained via finger-stick blood samples. We used latent profile analysis to identify resilience profiles and multinomial logistic regression to examine associations of profile classification with outcomes using relative risk ratios (RRR). Results: Distinct resilience profiles emerged: low (12.0% of sample), moderate (48.4%), and high (39.6%). Participants with lower perceived social support (RRR = 0.60 [95% confidence interval = 0.44–0.80], p < .001) and higher diabetes distress (RRR = 1.95 [1.35–2.82], p < .001) and depressive symptoms (RRR = 1.21 [1.11–1.31], p < .001) were more likely to be classified in the low vs. high resilience profile. Classification into the low vs. high resilience profile was also associated with clinically elevated depressive symptoms (RRR = 9.11 [3.40–24.42], p < .001) and clinically elevated HbA1c (RRR = 3.45 [1.20–9.93], p < .05). Conclusions: Psychological resilience clustered into distinct subgroups, with individuals in the low resilience profile exhibiting greater socioemotional and glycemic vulnerability. Findings support incorporating resilience-enhancing content into diabetes self-management programs to better assist vulnerable individuals and reduce diabetes-related disparities.
- 25 June 2026
- Published by Springer Nature in Journal of Racial and Ethnic Health Disparities
Open AccessPsychological Resilience Profiles and Their Association with Socioemotional Health and HbA1c Among African American Adults with Type 2 Diabetes: A Latent Profile Analysis
Objective: We used a cross-sectional design with baseline data from a Type 2 diabetes (T2D) clinical trial to (1) identify resilience profiles among African American adults with T2D and (2) examine the profiles’ associations with perceived social support, diabetes distress, depressive symptoms, and Hemoglobin A1c (HbA1c) levels. Methods: Participants ( n = 284, 72% women, 62 ± 11 years) recruited through churches in Central Texas completed a questionnaire assessing perceived psychological resilience, social support, diabetes distress, and depressive symptoms. HbA1c was obtained via finger-stick blood samples. We used latent profile analysis to identify resilience profiles and multinomial logistic regression to examine associations of profile classification with outcomes using relative risk ratios (RRR). Results: Distinct resilience profiles emerged: low (12.0% of sample), moderate (48.4%), and high (39.6%). Participants with lower perceived social support (RRR = 0.60 [95% confidence interval = 0.44–0.80], p < .001) and higher diabetes distress (RRR = 1.95 [1.35–2.82], p < .001) and depressive symptoms (RRR = 1.21 [1.11–1.31], p < .001) were more likely to be classified in the low vs. high resilience profile. Classification into the low vs. high resilience profile was also associated with clinically elevated depressive symptoms (RRR = 9.11 [3.40–24.42], p < .001) and clinically elevated HbA1c (RRR = 3.45 [1.20–9.93], p < .05). Conclusions: Psychological resilience clustered into distinct subgroups, with individuals in the low resilience profile exhibiting greater socioemotional and glycemic vulnerability. Findings support incorporating resilience-enhancing content into diabetes self-management programs to better assist vulnerable individuals and reduce diabetes-related disparities.
- Open Access
- 8 May 2025
- Published by Springer Nature in Research Square
Validation of Telli BP01 Oscillometric Blood Pressure Monitor According to AAMI/ESH/ISO Standard
The aim of the study was to evaluate the accuracy of a home-based oscillometric upper-arm blood pressure (BP) monitor (Telli BP01) in accordance with the Association for the Advancement of Medical Instrumentation/European Society of Hypertension/ International Organization for Standardization (AAMI/ESH/ISO) Universal Standard. Participants were recruited to fulfill the age, sex, BP, and cuff distribution criteria of the AAMI/ESH/ISO Universal Standard. Both the test device and the aneroid sphygmomanometer (observer BP) were connected to the BP cuff to measure BP simultaneously at rest and during maximal static hand grip (SHG). Ninety-two participants were recruited, and 85 were analyzed. Eleven participants were asked to perform SHG during the test. For validation Criterion 1, the mean ± SD of the differences (the test device minus observer BP) for all BP readings was − 1.8 ± 6.6/-3.7 ± 5.7 mmHg (systolic/diastolic). For validation Criterion 2, the SD of all participants' averaged BP differences (the test device minus observer BP per participant) was 5.5/4.9 mmHg (systolic/diastolic). Both criteria were fulfilled in the present validation study. In conclusion, the Telli BP01 BP monitor fulfilled the requirements of the AAMI/ESH/ISO Universal Standard (ISO 81060-2:2018) and can be recommended for use at home.
- 8 May 2025
- Published by Springer Nature in Research Square
Open AccessValidation of Telli BP01 Oscillometric Blood Pressure Monitor According to AAMI/ESH/ISO Standard
The aim of the study was to evaluate the accuracy of a home-based oscillometric upper-arm blood pressure (BP) monitor (Telli BP01) in accordance with the Association for the Advancement of Medical Instrumentation/European Society of Hypertension/ International Organization for Standardization (AAMI/ESH/ISO) Universal Standard. Participants were recruited to fulfill the age, sex, BP, and cuff distribution criteria of the AAMI/ESH/ISO Universal Standard. Both the test device and the aneroid sphygmomanometer (observer BP) were connected to the BP cuff to measure BP simultaneously at rest and during maximal static hand grip (SHG). Ninety-two participants were recruited, and 85 were analyzed. Eleven participants were asked to perform SHG during the test. For validation Criterion 1, the mean ± SD of the differences (the test device minus observer BP) for all BP readings was − 1.8 ± 6.6/-3.7 ± 5.7 mmHg (systolic/diastolic). For validation Criterion 2, the SD of all participants' averaged BP differences (the test device minus observer BP per participant) was 5.5/4.9 mmHg (systolic/diastolic). Both criteria were fulfilled in the present validation study. In conclusion, the Telli BP01 BP monitor fulfilled the requirements of the AAMI/ESH/ISO Universal Standard (ISO 81060-2:2018) and can be recommended for use at home.
- 1 December 2022
- Published by Springer Nature in Journal of Human Hypertension
- Vol. 37 (2) , 150-154
A new and specific automated blood pressure device for exercise stress testing
Blood pressure (BP) measurement plays a critical role in cardiac stress testing and is most commonly assessed manually. The emphasis of social distancing during the COVID-19 pandemic has renewed the interest in and the need for an automated BP device for incremental exercise stress testing. We assessed the accuracy of a new automated blood pressure device specifically manufactured for cardiac stress testing. Thirty-five adults aged 35 ± 16 years were studied during an incremental stress test on the cycle ergometer. Three observers measured BP simultaneously, two listening to Korotkoff sounds using a dual-headed stethoscope and one using headphones to listen to sounds generated by an automated BP device. With increasing workload, systolic BP increased progressively without significant differences in BP readings between any observer compared with the automated monitor at any stage during exercise. Systolic BP obtained with the BP machine was strongly correlated with those obtained by the stethoscope observers (r = 0.96) and the observer with headphones (r = 0.95). Diastolic BP obtained with the BP machine was moderately and significantly associated with those obtained by the stethoscope observers (r = 0.75) and the observer with headphones (r = 0.75). The automated BP monitor specifically made for cardiac stress testing accurately measured both systolic and diastolic blood pressure during exercise.
- 1 December 2022
- Published by Springer Nature in Journal of Human Hypertension
- Vol. 37 (2) , 150-154
A new and specific automated blood pressure device for exercise stress testing
Blood pressure (BP) measurement plays a critical role in cardiac stress testing and is most commonly assessed manually. The emphasis of social distancing during the COVID-19 pandemic has renewed the interest in and the need for an automated BP device for incremental exercise stress testing. We assessed the accuracy of a new automated blood pressure device specifically manufactured for cardiac stress testing. Thirty-five adults aged 35 ± 16 years were studied during an incremental stress test on the cycle ergometer. Three observers measured BP simultaneously, two listening to Korotkoff sounds using a dual-headed stethoscope and one using headphones to listen to sounds generated by an automated BP device. With increasing workload, systolic BP increased progressively without significant differences in BP readings between any observer compared with the automated monitor at any stage during exercise. Systolic BP obtained with the BP machine was strongly correlated with those obtained by the stethoscope observers (r = 0.96) and the observer with headphones (r = 0.95). Diastolic BP obtained with the BP machine was moderately and significantly associated with those obtained by the stethoscope observers (r = 0.75) and the observer with headphones (r = 0.75). The automated BP monitor specifically made for cardiac stress testing accurately measured both systolic and diastolic blood pressure during exercise.
- 4 June 2022
- Published by SAGE Publications in The Science of Diabetes Self-Management and Care
- Vol. 48 (4) , 204-212
Feasibility and Performance of Hemoglobin A1C Self-Testing During COVID-19 Among African Americans With Type 2 Diabetes
Purpose: The purpose of the study was to determine the feasibility of implementing A1C self-testing at home using the A1CNow® Self Check and to compare the accuracy of the A1CNow to a reference standard in African Americans with type 2 diabetes (T2D). Methods: African American adults with T2D were recruited from 13 different churches (N = 123). Phase 1, conducted during the early phase of the COVID-19 pandemic, examined the feasibility of A1C assessment using the A1CNow performed at home by untrained participants. Phase 2, conducted when in-person research resumed, compared A1C values concurrently measured using the A1CNow and the DCA Vantage™ Analyzer (reference standard) collected by research staff at church testing sites. Results: In Phase 1, 98.8% of participants successfully completed at least 1 at-home A1C test; the overall failure rate was 24.7%. In Phase 2, the failure rate of staff-performed A1CNow testing was 4.4%. The Bland-Altman plot reveals that A1CNow values were 0.68% lower than DCA values, and the mean differences (A1CNow minus DCA) ranged from −2.6% to 1.2% with a limit of agreement between −1.9% to 0.5%. Conclusions: A1C self-testing is feasible for use in community settings involving African American adults with T2D. The A1CNow Self-Check underestimated A1C values when compared with the reference standard. Ongoing improvements in point-of-care devices have the potential to expand research and clinical care, especially in underserved communities.
- 4 June 2022
- Published by SAGE Publications in The Science of Diabetes Self-Management and Care
- Vol. 48 (4) , 204-212
Feasibility and Performance of Hemoglobin A1C Self-Testing During COVID-19 Among African Americans With Type 2 Diabetes
Purpose: The purpose of the study was to determine the feasibility of implementing A1C self-testing at home using the A1CNow® Self Check and to compare the accuracy of the A1CNow to a reference standard in African Americans with type 2 diabetes (T2D). Methods: African American adults with T2D were recruited from 13 different churches (N = 123). Phase 1, conducted during the early phase of the COVID-19 pandemic, examined the feasibility of A1C assessment using the A1CNow performed at home by untrained participants. Phase 2, conducted when in-person research resumed, compared A1C values concurrently measured using the A1CNow and the DCA Vantage™ Analyzer (reference standard) collected by research staff at church testing sites. Results: In Phase 1, 98.8% of participants successfully completed at least 1 at-home A1C test; the overall failure rate was 24.7%. In Phase 2, the failure rate of staff-performed A1CNow testing was 4.4%. The Bland-Altman plot reveals that A1CNow values were 0.68% lower than DCA values, and the mean differences (A1CNow minus DCA) ranged from −2.6% to 1.2% with a limit of agreement between −1.9% to 0.5%. Conclusions: A1C self-testing is feasible for use in community settings involving African American adults with T2D. The A1CNow Self-Check underestimated A1C values when compared with the reference standard. Ongoing improvements in point-of-care devices have the potential to expand research and clinical care, especially in underserved communities.
- Open Access
- 30 December 2021
- Published by JMIR Publications Inc. in JMIR Perioperative Medicine
- Vol. 4 (2) , e32575
A Mobile App With Multimodality Prehabilitation Programs for Patients Awaiting Elective Surgery: Development and Usability Study
Background: Complying with a prehabilitation program is difficult for patients who will undergo surgery, owing to transportation challenges and a limited intervention time window. Mobile health (mHealth) using smartphone apps has the potential to remove barriers and improve the effectiveness of prehabilitation. Objective: This study aimed to develop a mobile app as a tool for facilitating a multidisciplinary prehabilitation protocol involving blood flow restriction training and sport nutrition supplementation. Methods: The app was developed using “Appy Pie,” a noncoding app development platform. The development process included three stages: (1) determination of principles and requirements of the app through prehabilitation research team meetings; (2) app prototype design using the Appy Pie platform; and (3) app evaluation by clinicians and exercise and fitness specialists, technical professionals from Appy Pie, and non–team-member users. Results: We developed a prototype of the app with the core focus on a multidisciplinary prehabilitation program with accessory features to improve engagement and adherence to the mHealth intervention as well as research-focused features to evaluate the effects of the program on frailty status, health-related quality of life, and anxiety level among patients awaiting elective surgery. Evaluations by research members and random users (n=8) were consistently positive. Conclusions: This mobile app has great potential for improving and evaluating the effectiveness of the multidisciplinary prehabilitation intervention in the format of mHealth in future.
- 30 December 2021
- Published by JMIR Publications Inc. in JMIR Perioperative Medicine
- Vol. 4 (2) , e32575
Open AccessA Mobile App With Multimodality Prehabilitation Programs for Patients Awaiting Elective Surgery: Development and Usability Study
Background: Complying with a prehabilitation program is difficult for patients who will undergo surgery, owing to transportation challenges and a limited intervention time window. Mobile health (mHealth) using smartphone apps has the potential to remove barriers and improve the effectiveness of prehabilitation. Objective: This study aimed to develop a mobile app as a tool for facilitating a multidisciplinary prehabilitation protocol involving blood flow restriction training and sport nutrition supplementation. Methods: The app was developed using “Appy Pie,” a noncoding app development platform. The development process included three stages: (1) determination of principles and requirements of the app through prehabilitation research team meetings; (2) app prototype design using the Appy Pie platform; and (3) app evaluation by clinicians and exercise and fitness specialists, technical professionals from Appy Pie, and non–team-member users. Results: We developed a prototype of the app with the core focus on a multidisciplinary prehabilitation program with accessory features to improve engagement and adherence to the mHealth intervention as well as research-focused features to evaluate the effects of the program on frailty status, health-related quality of life, and anxiety level among patients awaiting elective surgery. Evaluations by research members and random users (n=8) were consistently positive. Conclusions: This mobile app has great potential for improving and evaluating the effectiveness of the multidisciplinary prehabilitation intervention in the format of mHealth in future.
- Open Access
- 3 August 2021
- Published by JMIR Publications Inc. in JMIR Preprints
A Mobile App With Multimodality Prehabilitation Programs for Patients Awaiting Elective Surgery: Development and Usability Study (Preprint)
BACKGROUND Complying with a prehabilitation program is difficult for patients who will undergo surgery, owing to transportation challenges and a limited intervention time window. Mobile health (mHealth) using smartphone apps has the potential to remove barriers and improve the effectiveness of prehabilitation. OBJECTIVE This study aimed to develop a mobile app as a tool for facilitating a multidisciplinary prehabilitation protocol involving blood flow restriction training and sport nutrition supplementation. METHODS The app was developed using “Appy Pie,” a noncoding app development platform. The development process included three stages: (1) determination of principles and requirements of the app through prehabilitation research team meetings; (2) app prototype design using the Appy Pie platform; and (3) app evaluation by clinicians and exercise and fitness specialists, technical professionals from Appy Pie, and non–team-member users. RESULTS We developed a prototype of the app with the core focus on a multidisciplinary prehabilitation program with accessory features to improve engagement and adherence to the mHealth intervention as well as research-focused features to evaluate the effects of the program on frailty status, health-related quality of life, and anxiety level among patients awaiting elective surgery. Evaluations by research members and random users (n=8) were consistently positive. CONCLUSIONS This mobile app has great potential for improving and evaluating the effectiveness of the multidisciplinary prehabilitation intervention in the format of mHealth in future.
- 3 August 2021
- Published by JMIR Publications Inc. in JMIR Preprints
Open AccessA Mobile App With Multimodality Prehabilitation Programs for Patients Awaiting Elective Surgery: Development and Usability Study (Preprint)
BACKGROUND Complying with a prehabilitation program is difficult for patients who will undergo surgery, owing to transportation challenges and a limited intervention time window. Mobile health (mHealth) using smartphone apps has the potential to remove barriers and improve the effectiveness of prehabilitation. OBJECTIVE This study aimed to develop a mobile app as a tool for facilitating a multidisciplinary prehabilitation protocol involving blood flow restriction training and sport nutrition supplementation. METHODS The app was developed using “Appy Pie,” a noncoding app development platform. The development process included three stages: (1) determination of principles and requirements of the app through prehabilitation research team meetings; (2) app prototype design using the Appy Pie platform; and (3) app evaluation by clinicians and exercise and fitness specialists, technical professionals from Appy Pie, and non–team-member users. RESULTS We developed a prototype of the app with the core focus on a multidisciplinary prehabilitation program with accessory features to improve engagement and adherence to the mHealth intervention as well as research-focused features to evaluate the effects of the program on frailty status, health-related quality of life, and anxiety level among patients awaiting elective surgery. Evaluations by research members and random users (n=8) were consistently positive. CONCLUSIONS This mobile app has great potential for improving and evaluating the effectiveness of the multidisciplinary prehabilitation intervention in the format of mHealth in future.